Level A· Stronger Clinical EvidenceMeta-analysisEurope PMCOpen access

Association between platelet to lymphocyte ratio and the risk of vertebral fracture in patients with osteoporosis: a systematic review and meta-analysis

Hu F., Zhan Y., Yao J., Cheng M., Wang J.

Meta-analysis on Back & Spine, published in Front Endocrinol (Lausanne) (2026) — summary generated from the PubMed abstract.

Open my reading list
Level A· Stronger Clinical EvidenceEvidence level of this study

Relatively higher-quality human studies compared with other topics in this database, e.g. multiple RCTs or systematic reviews. This does not mean it is standard or approved care.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Meta-analysis
Journal
Front Endocrinol (Lausanne) (2026)
Reported sample size
—
Source database
Europe PMC
PMID
41958875
PMCID
PMC13056836
DOI
10.3389/fendo.2026.1705468

Abstract (original English)

Background Vertebral fractures, accounting for 40% of osteoporotic fractures, often lack early clinical symptoms, necessitating improved risk prediction biomarkers. This meta-analysis was the first to evaluate the association between platelet-to-lymphocyte ratio (PLR) and vertebral fracture risk in osteoporosis patients. Methods We systematically searched PubMed, Embase, Web of Science, Cochrane, Wanfang and CNKI (up to July 2025). Odds ratio (OR) and standardized mean difference (SMD) with 95% confidence intervals (CIs) were used for the data synthesis of categorical and continuous variables, respectively. Sensitivity analysis was performed to explore the stability of the results and potential sources of heterogeneity. All analyses were performed using Review Manager 5.4 and STATA 15.0. Results Seven observational studies were included. Categorical data showed significantly higher vertebral fracture risk in high-PLR groups (OR: 1.02; 95% CI: 1.00, 1.03; P = 0.01). Continuous data revealed a significantly higher PLR level in the fracture group compared with the non-fracture group (SMD: 1.78; 95% CI: 0.32, 3.25; P = 0.02). No significant publication bias was detected for either categorical or continuous variables. Sensitivity analyses revealed instability in both categorical and continuous outcomes and found that the Di et al., 2024 and Song et al., 2022-II studies might be the

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Relatively higher-quality human studies compared with other topics in this database, e.g. multiple RCTs or systematic reviews. This does not mean it is standard or approved care.

How we grade evidence
Blood PlateletsLymphocytesHumansOsteoporosisSpinal FracturesLymphocyte CountPlatelet CountRisk FactorsOsteoporotic FracturesBiomarkers

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research